‘Left wondering’

This rapid response by Shirley Nurock was made in response to a BMJ report that the US drug company Biogen is “walking away from its Alzheimer’s drug aducanumab (Aduhelm).” In … Continue reading ‘Left wondering’

I write as ‘one of those’.

The following response was written by myself over a decade ago. The recent extensive promotion of Scottish Brain Sciences reminded me of it. Response to the head to head debate: … Continue reading I write as ‘one of those’.

Anti-amyloid drugs: Key questions

As published here.

Accelerated approval of anti-amyloid drugs

I fully share the concerns expressed by Professor Robert Howard: